(Q46644678)

23 December 2017

title

Stress-induced analgesia in mice: evidence for interaction between endocannabinoids and cholecystokinin (English)

1 reference

23 December 2017

0 references

1 reference

1

1 reference

23 December 2017

Toshimitsu Matsui

series ordinal

3

1 reference

23 December 2017

Eero Vasar

series ordinal

4

object named as

Eero Vasar

1 reference

23 December 2017

Jan Inno

2

1 reference

23 December 2017

language of work or name

English

0 references

publication date

1 April 2008

1 reference

23 December 2017

European Journal of Neuroscience

published in

1 reference

23 December 2017

volume

27

1 reference

23 December 2017

issue

8

1 reference

23 December 2017

page(s)

2147-2155

1 reference

23 December 2017

The many possible roles of opioids and related peptides in stress-induced analgesia

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2008.06160.X

Striatal dopamine D2 receptors attenuate neuropathic hypersensitivity in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2008.06160.X

The role of CCK caerulein, and CCK antagonists in nociception

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2008.06160.X

Activation of CB1 cannabinoid receptors in rat hippocampal slices inhibits potassium-evoked cholecystokinin release, a possible mechanism contributing to the spatial memory defects produced by cannabinoids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2008.06160.X

Evidence for the Neuropeptide Cholecystokinin as an Antagonist of Opiate Analgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2008.06160.X

Spinal and peripheral mechanisms of cannabinoid antinociception: behavioral, neurophysiological and neuroanatomical perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2008.06160.X

An endocannabinoid mechanism for stress-induced analgesia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2008.06160.X

Deletion of the CCK2 receptor gene reduces mechanical sensitivity and abolishes the development of hyperalgesia in mononeuropathic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2008.06160.X

Opioid and nonopioid mechanisms of stress analgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2008.06160.X

Evidence for an involvement of supraspinal delta- and spinal mu-opioid receptors in the antihyperalgesic effect of chronically administered clomipramine in mononeuropathic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2008.06160.X

Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2008.06160.X

G protein-coupled cholecystokinin-B/gastrin receptors are responsible for physiological cell growth of the stomach mucosa in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2008.06160.X

CCK-B receptor: chemistry, molecular biology, biochemistry and pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2008.06160.X

Suppression of the morphine-induced rewarding effect in the rat with neuropathic pain: implication of the reduction in mu-opioid receptor functions in the ventral tegmental area

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2008.06160.X

Distinct changes in the behavioural effects of morphine and naloxone in CCK2 receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2008.06160.X

Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2008.06160.X

Cholecystokinin and morphine analgesia: variations on a theme

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2008.06160.X

2-Arachidonoylglycerol and the cannabinoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2008.06160.X

Endocannabinoids at the spinal level regulate, but do not mediate, nonopioid stress-induced analgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2008.06160.X

Two opioid forms of stress analgesia: studies of tolerance and cross-tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2008.06160.X

Opioid and non-opioid stress analgesia from cold water swim: importance of stress severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2008.06160.X

Reduction of stress-induced analgesia but not of exogenous opioid effects in mice lacking CB1 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2008.06160.X

The neurobiology of cannabinoid analgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2008.06160.X

Cholecystokinin/opioid interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2008.06160.X

10.1111/J.1460-9568.2008.06160.X

21 January 2018

Identifiers

DOI

1 reference

23 December 2017

1 reference

23 December 2017